SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-21-000388
Filing Date
2021-11-22
Accepted
2021-11-22 16:32:02
Documents
54
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q eucr-20210930x10q.htm   iXBRL 10-Q 1066403
2 EXHIBIT 31.1 eucr-20210930xex31d1.htm EX-31.1 11806
3 EXHIBIT 31.2 eucr-20210930xex31d2.htm EX-31.2 16561
4 EXHIBIT 32.1 eucr-20210930xex32d1.htm EX-32.1 6915
5 EXHIBIT 32.2 eucr-20210930xex32d2.htm EX-32.2 6951
  Complete submission text file 0001410578-21-000388.txt   5213035

Data Files

Seq Description Document Type Size
6 EX-101.SCH eucr-20210930.xsd EX-101.SCH 41809
7 EX-101.CAL eucr-20210930_cal.xml EX-101.CAL 18079
8 EX-101.DEF eucr-20210930_def.xml EX-101.DEF 141422
9 EX-101.LAB eucr-20210930_lab.xml EX-101.LAB 292852
10 EX-101.PRE eucr-20210930_pre.xml EX-101.PRE 236057
11 EXTRACTED XBRL INSTANCE DOCUMENT eucr-20210930x10q_htm.xml XML 1092442
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates Biomedical Acquisition Corp. (Filer) CIK: 0001822929 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 10-Q | Act: 34 | File No.: 001-39650 | Film No.: 211432984
SIC: 6770 Blank Checks